Chen I-Wen, Wang Wei-Ting, Hung Kuo-Chuan
Department of Anesthesiology, Chi Mei Medical Center, Liouying, Tainan City, Taiwan.
Department of Anesthesiology, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan.
PLoS One. 2025 Feb 24;20(2):e0319107. doi: 10.1371/journal.pone.0319107. eCollection 2025.
This meta-analysis aimed to quantitatively synthesize evidence on the association between the preoperative neutrophil-to-lymphocyte ratio (NLR) and the risk of deep vein thrombosis (DVT) in patients undergoing lower extremity orthopedic surgery.
Medline, Embase, Google Scholar, and the Cochrane Library were systematically searched for observational studies that examined the relationship between preoperative NLR and DVT risk in patients undergoing lower extremity procedures. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using random-effects models.
Ten studies involving 5,697 patients were included in the meta-analysis. The pooled incidence of DVT across the studies was 13.8% (95% CI: 9.7%-19.2%). Elevated NLR was associated with a two-fold increase in the risk of DVT (odds ratio [OR] 2.08, 95% confidence interval [CI]: 1.39-3.12, p = 0.0004, I2 = 85%). Patients who developed DVT had a higher NLR than those who did not (mean difference: 0.93, 95% CI: 0.37 to 1.48, p = 0.001, I2 = 86%). Among the patient characteristics, male sex (OR 1.51, 95% CI: 1.12-2.03), diabetes mellitus (OR 1.60, 95% CI: 1.06-2.41), and hypertension (OR 1.43, 95% CI: 1.06-1.93) were significantly associated with increased DVT risk. Subgroup analysis based on the timing of DVT occurrence (preoperative vs. postoperative) revealed no significant difference in the association between NLR and DVT risk.
Elevated preoperative NLR was significantly associated with increased DVT risk in patients undergoing lower extremity orthopedic surgery. NLR may serve as a useful biomarker for DVT risk stratification in this population. Prospective studies are needed to validate its predictive value and evaluate NLR-guided thromboprophylaxis strategies.
PROSPERO registration number: CRD42024577952.
本荟萃分析旨在定量综合有关术前中性粒细胞与淋巴细胞比值(NLR)与接受下肢骨科手术患者深静脉血栓形成(DVT)风险之间关联的证据。
系统检索了Medline、Embase、谷歌学术和考克兰图书馆,以查找研究术前NLR与接受下肢手术患者DVT风险之间关系的观察性研究。使用随机效应模型计算合并比值比(OR)及95%置信区间(CI)。
荟萃分析纳入了10项涉及5697例患者的研究。各研究中DVT的合并发生率为13.8%(95%CI:9.7%-19.2%)。NLR升高与DVT风险增加两倍相关(比值比[OR]2.08,95%置信区间[CI]:1.39-3.12,p = 0.0004,I² = 85%)。发生DVT的患者NLR高于未发生DVT的患者(平均差值:0.93,95%CI:0.37至1.48,p = 0.001,I² = 86%)。在患者特征中,男性(OR 1.51,95%CI:1.12-2.03)、糖尿病(OR 1.60,95%CI:1.06-2.41)和高血压(OR 1.43,95%CI:1.06-1.93)与DVT风险增加显著相关。基于DVT发生时间(术前与术后)的亚组分析显示,NLR与DVT风险之间的关联无显著差异。
术前NLR升高与接受下肢骨科手术患者的DVT风险增加显著相关。NLR可作为该人群DVT风险分层的有用生物标志物。需要进行前瞻性研究以验证其预测价值并评估以NLR为指导的血栓预防策略。
PROSPERO注册号:CRD42024577952。